Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic disease of the joints that can cause a disabling degree of pain and significantly interfere with an individual’s day-to-day living.

What is Rheumatoid Arthritis?

Rheumatoid arthritis or RA is an inflammatory condition that affects joints primarily leading to pain and stiffness and difficulty in movements. Commonly affected joints are those of the hands, feet and wrists. RA however can also affect other parts of the body.

Psoriatic Arthritis vs Rheumatoid Arthritis

Disease-Modifying AntiRheumatic Drugs (DMARDs)

Rheumatoid Arthritis and Gout

Juvenile Rheumatoid Arthritis Treatment

Yoga and Tai chi in Rheumatoid Arthritis

Rheumatoid Arthritis and Winter Weather

Rheumatoid Arthritis and Pregnancy

Rheumatoid Arthritis Management

Rheumatoid Arthritis and Feet

Rheumatoid Factor Test

Self-Help and Living with Rheumatoid Arthritis

See more featured articles »

Juvenile Rheumatoid Arthritis Diagnosis

Juvenile Rheumatoid Arthritis

Rheumatoid Arthritis Diet and Nutrition

Rheumatoid Arthritis Support

Causes of Hand Pain

Can Antibiotics Increase the Risk of Arthritis?

Rheumatoid Arthritis and Acupuncture

Rheumatoid Arthritis Treatment

Rheumatoid Arthritis Nodules

Hip Rheumatoid Arthritis

Rheumatoid Arthritis Prognosis

Rheumatoid Arthritis Diagnosis

Rheumatoid Arthritis Skin Problems

Are There Any Natural Remedies for Rheumatoid Arthritis?

Radiotherapy and Rheumatoid Arthritis

Knee Rheumatoid Arthritis

Rheumatoid Arthritis and Vitamin D

Rheumatoid Arthritis and Depression

Rheumatoid Arthritis and Gum Disease

Total Knee Replacement and Rheumatoid Arthritis

Rheumatoid Arthritis, Family Planning & Pregnancy

Rheumatoid Arthritis History

What Causes Rheumatoid Arthritis?

Rheumatoid Arthritis Epidemiology

Juvenile Rheumatoid Arthritis Symptoms

Juvenile Rheumatoid Arthritis Types

Rheumatoid Arthritis and Exercise

Rheumatoid Arthritis Complications

Rheumatoid Arthritis Research

Rheumatoid Arthritis Symptoms

Latest Rheumatoid Arthritis News and Research

Review finds vitamin D lacks disease-modifying effect in rheumatic diseases

A new review from the International Osteoporosis Foundation (IOF) Osteoimmunology Working Group, published in Osteoporosis International, provides a comprehensive evaluation of the role of vitamin D in inflammatory rheumatic diseases.

8 Jun 2026

GLP-1 therapies linked to fewer complications in adults with both obesity and autoimmune disease

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious cardiac events, such as stroke, pulmonary embolism or death when compared to similar adults who were not taking these medications, according to new research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

7 Jun 2026

Patient organizations strengthen support for people with rheumatic diseases

Rheumatic and musculoskeletal diseases (RMD) are chronic, often lifelong conditions. EULAR - The European Alliance of Associations for Rheumatology - works with the network of national organizations of People with Arthritis/Rheumatism in Europe (PARE) to ensure the voices of people with RMD are heard and have influence among decision makers - creating powerful alliances that make a real difference to lives.

7 Jun 2026

EULAR Congress highlights innovative support strategies for rheumatology patients

Rheumatic and musculoskeletal diseases (RMD) profoundly impact daily life, limiting both work ability and participation in everyday activities.

5 Jun 2026

EULAR 2026 highlights rising comorbidity risks in rheumatic disease

People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular diseases to cognitive impairment and fractures.

4 Jun 2026

Real-world study exposes suboptimal adherence to treat-to-target rheumatic strategies

EULAR - The European Alliance of Associations for Rheumatology - acknowledges the role of diverse real-world data to complement knowledge from randomized controlled trials.

4 Jun 2026

CAR-T cell therapy shows promise for treating rheumatoid arthritis

Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare.

3 Jun 2026

Continuing gout therapy during remission lowers future flare risk

The European Alliance of Associations for Rheumatology - held its 2026 annual Congress in London, where gout was high on the agenda.

3 Jun 2026

Vaginal bromocriptine may ease pain and heavy bleeding in adenomyosis

A pilot randomized controlled trial found that vaginal bromocriptine reduced menstrual bleeding, pelvic pain, menstrual duration, and cycle irregularity in women with adenomyosis compared with routine treatment.

27 May 2026

Pim1 identified as promising therapeutic target for inflammatory arthritis treatment

The research team led by Professor Zhongyu Xie from Sun Yat-sen University revealed a new mechanism by which Pim1 regulated Th17 cell differentiation through mitochondrial metabolism.

22 May 2026

Anti-inflammatory drug tocilizumab shows promise for difficult-to-treat depression

Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomised controlled clinical trial, published in JAMA Psychiatry today [20 May].

20 May 2026

Largest blood protein genetics study reveals new precision medicine opportunities

Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from Queen Mary University of London's Precision Healthcare University Research Institute and Berlin Institute of Health (BIH) at Charité have led the world's largest study on the genetic regulation of blood proteins.

6 May 2026

Study reveals new immune mechanism behind mevalonate kinase deficiency

Researchers at the Garvan Institute of Medical Research have uncovered a critical mechanism driving inflammation in mevalonate kinase deficiency (MKD), a rare but devastating autoinflammatory disorder.

30 Apr 2026

Survey reveals silica dust risks for Australia’s tunnel workers

The responses to a national survey published today have revealed tunnel construction workers across Australia say they face significant exposure to silica dust, a hazardous dust that can cause incurable diseases like silicosis and lung cancer.

29 Apr 2026

Scientists identify specialized cells that trigger bone marrow cavity growth

Bone marrow is the spongy tissue located within the hollow center of bones, serving as the primary site for the continuous production of red blood cells, platelets, and white blood cells.

28 Apr 2026

Natural compound obakulactone shows therapeutic potential for rheumatoid arthritis

A new study published in Engineering reveals that obakulactone (OL), a natural tetracyclic triterpenoid isolated from Phellodendri cortex, exerts a therapeutic effect on rheumatoid arthritis (RA) by promoting the degradation of acyl coenzyme A thioesterase 1 (ACOT1) via the ubiquitin‒proteasome pathway and restoring the homeostasis of unsaturated fatty acids.

25 Apr 2026

Patient outcomes vary by drug class despite achieving clinical remission

A study published in Rheumatology & Autoimmunity challenges the assumption that achieving clinical remission in rheumatoid arthritis is sufficient, showing that patient-reported outcomes vary significantly by drug class even when disease activity is comparable.

22 Apr 2026

An Arm and a Leg: The accidental architect of America’s drug patent problem

Depending on whom you ask, Alfred Engelberg could be a hero or a villain in the story of American pharmaceuticals.

20 Apr 2026

Why AI is becoming a powerful tool in cancer drug discovery

This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical translation, with an AI-designed TNIK inhibitor trial serving as an important proof-of-feasibility reference point. It argues that precision oncology could benefit from AI-driven integration of multi-omics, federated learning, and adaptive trial design, but only if validation, fairness, interpretability, and regulatory alignment improve.

16 Apr 2026

Researchers identify molecular link between autoimmune disease and lymphoma risk

Patients with autoimmune diseases such as lupus and rheumatoid arthritis have an increased risk of developing lymphoma, a form of blood cancer that affects the lymphatic system.

13 Apr 2026